tirzepatide label These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO.MOUNJARO® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 1 and GIP therapy Tirzepatide Vial Online | Compounded

Add More Fiber, Gradually Fiber adds bulk to your stool and helps it move through your system more efficiently

Clinical Evidence for Weekly Dosing Frequency The SURMOUNT-1 trial enrolled over 2,000 adults with obesity and tracked weight loss over 68 weeks using weekly tirzepatide dosing

GLP-1 receptor agonists can help treat obesity and promote weight loss by slowing gastric emptying, making you feel fuller longer, and also slowing the release of glucose into your bloodstream

Importantly, tirzepatide is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis

It sounds simple, but it works

The concentration per sip is completely different